Original Articles
Visualizações

Arq. Bras. Oftalmol. 2022; 85 (5): 10.5935/0004-2749.20220075

Total: 2320

Carboplatin-loaded surface modified-PLGA nanoparticles confer sustained inhibitory effect against retinoblastoma cell in vitro

Hua Zhuang1,2; Ya-Nan Xu3,4; Hong-Hua Zheng3,4; Yu-Rong Huan3,4; Ning-Xuan Zheng5; Lin Lin6; Wu-Zhen Zhang1; Wei Xu7

DOI: 10.5935/0004-2749.20220075

1. Xianyou Maternity and Childcare Hospital, Putian, 351200, Fujian Province, China
2. Fujian Medical University, Fujian Province, China
3. Aier School of Ophthalmology, Central South University, Changsha, 410083, Hunan Province, China
4. Fuzhou Aier Eye Hospital, China
5. Fujian Center for Disease Control and Prevention, Fu Zhou 350000, Fujian Province, China
6. Women and Children’s Hospital Affiliated to Xiamen University, Xiamen, 361000, Fujian Province, China
7. The 1st affiliated Hospital of Fujian Medical University, Fuzhou, Fujian Province, China

Corresponding author

Wei Xu
E-mail: [email protected]

Approved by the following research ethics committee: The 1st affiliated Hospital of Fujian Medical University (#201730125).

Disclosure of potential conflicts of interest: None of the authors has any potential conflicts of interest to disclose.


Print PDF English
Open Access
Share

How to cite this article:

Zhuang1 H, 2 , Xu3 Y, 4 , Zheng3 H, 4 , et al. Nanopartículas de PLGA com superfície modificada carregada com carboplatina conferem efeito inibitório sustentado contra células de retinoblastoma in vitro. Arq. Bras. Oftalmol. 2022;85(5):. 10.5935/0004-2749.20220075
Export citation